Clinical Trial Update: A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With Linvoseltamab in Adult Participants With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and anti-tumor activity of REGN7945 in combination with Linvoseltamab in adults with relapsed/refractory multip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Linvoseltamab
• REGN7945

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Relapsed/Refractory Multiple Myeloma | Phase 1, Phase 2 | Status: RECRUITING